Talking Euretina
En podcast av Whipsmart Media
60 Avsnitt
-
Episode 39: The Euretina Retinal Medicine Clinical Research Award
Publicerades: 2023-11-15 -
Episode 38: Preview of Euretina Congress 2023
Publicerades: 2023-09-29 -
Episode 37: Blind Faith - How RP patients are being targeted with bad science across the world
Publicerades: 2023-09-15 -
Episode 36: The Ophthalmologica Lecture: Maximilian Pfau
Publicerades: 2023-09-01 -
Episode 35: Treating PCV and Pachychoroid in Different Populations
Publicerades: 2023-08-15 -
Episode 34: The Euretina Lecture: OncoVR
Publicerades: 2023-07-31 -
Episode 33: The Euretina Innovation Summit - All You Need to Know
Publicerades: 2023-07-03 -
Episode 32: Macular Holes and Glaucoma in Myopia
Publicerades: 2023-06-15 -
Episode 31: Featured studies from the Ophthalmologica journal
Publicerades: 2023-05-18 -
Episode 30: Intraocular Lymphoma: An Explainer
Publicerades: 2023-05-02 -
Episode 29: How to get published in Euretina’s Journal, Ophthalmologica
Publicerades: 2023-04-14 -
Episode 28: Diabetic Retinopathy - the latest exciting developments from across the world
Publicerades: 2023-03-30 -
Episode 27: What do we mean by ”macula-off” RRD ... and how soon should we act?
Publicerades: 2023-03-14 -
Episode 26: Tackling Acute Retinal Necrosis in Patients
Publicerades: 2023-03-01 -
Episode 25: What individual patient data can tell us about treating macular holes
Publicerades: 2023-02-15 -
Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
Publicerades: 2023-02-06 -
Episode 23: Everything You Need to Know About the New EBO-Euretina Exam
Publicerades: 2023-01-17 -
Episode 22: Women in Retina
Publicerades: 2022-12-01 -
Episode 21: What To Know About The Bad Guy In Myopia: Staphyloma
Publicerades: 2022-11-17 -
Episode 20: A Deep Dive into the MOLES System
Publicerades: 2022-11-03
Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.
